Point72 Asset Management »

Neubase Therapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Neubase Therapeutics (NBSE) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Neubase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neubase Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neubase Therapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $28k 63k 0.45
2023-12-31 $46k 63k 0.74
2023-09-30 $54k 63k 0.87
2023-06-30 $117k 63k 1.87